Connect with us

Technology

10x Genomics Launches 5,000-Plex Gene Panel for Xenium

Published

2 years ago

on

 New Xenium Prime 5K Pan-Tissue and Pathways panel increases plex by an order of magnitude and delivers industry-leading speed and throughput

PLEASANTON, Calif., May 29, 2024 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the launch of its Xenium Prime 5K Pan-Tissue and Pathways panel. The new assay features an enhanced chemistry to increase plex by an order of magnitude while delivering excellent per-gene sensitivity, improved specificity and spatial fidelity, integrated multimodal cell segmentation, and industry-leading speed and throughput.

“Seeing the Xenium Prime 5K data reminded me of the excitement I experienced when I saw single cell RNA-seq data for the first time,” said Dr. Kevin Wei, M.D., Ph.D., Assistant Professor of Medicine at Harvard Medical School. “Now, we can identify relevant molecular pathways in human diseases and explore new biological hypotheses, all from one glass slide.”

The high-plex Xenium Prime 5K assay enables a new level of exploration for pathways, biomarkers, ligand-receptor pairings and cell-cell interactions. Key features include:

Highest plex Xenium panel for comprehensive profiling of cell types and states and cell signaling pathways across multiple tissue and disease types.Excellent data quality to unlock mechanisms of disease, therapeutics and cell behavior. The Xenium Prime 5K assay is optimized for performance and paired with 10x Genomics’ advanced multimodal cell segmentation, enabling high sensitivity, specificity and spatial fidelity.Rapid turnaround time with easy, tissue-agnostic workflows. 10x Genomics’ industry-leading throughput enables researchers to analyze up to 472 mm² of tissue in six days or less.Easily customizable with up to 100 additional genes to capture customers’ specific research needs.Rigorously designed and developed using single cell RNA-seq data from dozens of different organs and tissues, gene expression profiles from hundreds of cell types and a screen of more than 750,000 peer-reviewed publications to pinpoint highly cited biomarkers.

“We successfully launched Xenium with a broad menu of curated and highly customizable gene panels so customers could target specific biology important for their research,” said Michael Schnall-Levin, Founding Scientist and Chief Technology Officer at 10x Genomics. “With the launch of our 5K gene panel, researchers can now also use Xenium for spatial exploration, enabling more biology and more breakthroughs. This assay is yet another example of how we put our innovation engine to work for our customers and build best-in-class products that deliver best-in-class results.”

The Xenium Prime 5K assay, optimized for human and mouse species, is now available for preorder and is expected to ship next month.

About 10x Genomics
10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world’s understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn or X (Twitter).

Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which fall under the “safe harbor” provisions of those sections. All statements, other than statements of historical facts, may be forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “may,” “might,” “will,” “should,” “expect,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential” or “continue” or variations of them or similar terminology, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements include statements regarding 10x Genomics, Inc.’s (“10x Genomics”) product launches, performance, configuration, capabilities, adoption and pipeline. These statements are based on management’s current expectations, forecasts, beliefs, assumptions and information currently available to management, and actual outcomes and results could differ materially from these statements due to a number of factors. Other risks and uncertainties that could affect 10x Genomics’ financial and operating results and cause actual results to differ materially from those indicated by the forward-looking statements made in this press release include those discussed under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in the documents 10x Genomics files with the Securities and Exchange Commission (the “SEC”) from time to time. Although 10x Genomics believes that the expectations reflected in the forward-looking statements are reasonable, it cannot provide any assurance that these expectations will prove to be correct nor can it guarantee that the future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or occur. The forward-looking statements in this press release are based on information available to 10x Genomics as of the date hereof, and 10x Genomics disclaims any obligation to update any forward-looking statements provided to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law. These forward-looking statements should not be relied upon as representing 10x Genomics’ views as of any date subsequent to the date of this press release.

Disclosure Information
10x Genomics uses filings with the Securities and Exchange Commission, our website (www.10xgenomics.com), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD.

Contacts
Investors: investors@10xgenomics.com
Media: media@10xgenomics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-launches-5-000-plex-gene-panel-for-xenium-302158495.html

SOURCE 10x Genomics, Inc

Related Topics:
Continue Reading

Technology

Longbridge and SIAS sign MoU to advance investor education and financial literacy in the AI era

Published

3 seconds ago

on

October 26, 2026

By

Collaboration combines market insights, practical workshops and community outreach to help investors build financial knowledge and use digital tools thoughtfully

SINGAPORE, Oct. 26, 2026 /PRNewswire/ — Longbridge Securities Singapore (“Longbridge”) and the Securities Investors Association (Singapore) (“SIAS”) today signed a Memorandum of Understanding (MoU) to advance investor education and enhance financial literacy in an increasingly AI-enabled investing environment.

The MoU establishes a framework for collaboration across investor education, community engagement and practical learning. It brings together SIAS’s longstanding commitment to investor education and advocacy with Longbridge’s technology and platform capabilities, with a shared aim of helping retail investors make better-informed decisions.

As AI changes how investors access information and research markets, both organisations believe that financial knowledge and the ability to assess information critically are increasingly important. The collaboration seeks to help investors understand market developments, build practical research skills and develop greater confidence in using digital tools, while recognising their limitations.

“AI is opening up new possibilities for investors to explore information, understand markets and ask better questions. Financial education is essential to helping people make meaningful use of those possibilities. Through our collaboration with SIAS, we want to bring technology and learning closer together, giving investors opportunities to build their knowledge and practise using these tools. This MoU reflects our commitment to supporting a more informed and confident investing community in Singapore,” said Gavin Chia, Singapore and Regional CEO, Southeast Asia, Longbridge Securities.

The collaboration will bring learning into a range of settings, from market outlook sessions and hands-on workshops at Longbridge Café to community and heartland programmes. These activities aim to connect financial concepts with practical experience, making investor education relevant to people with different levels of market knowledge and digital confidence.

“Investor education must evolve as the tools available to investors change. Alongside financial fundamentals, investors need to know how to question information, assess its relevance and understand the limitations of AI-generated responses. Our collaboration with Longbridge aims to make this learning accessible and practical, reaching people with different levels of investing experience and digital confidence. We look forward to helping more investors develop the knowledge and judgment to make informed decisions,” said Ang Hao Yao, Vice President, SIAS.

About Longbridge Securities Singapore

Longbridge Securities is an AI-Powered online brokerage headquartered in Singapore. By building global trading infrastructure and a trading network, it delivers best-in-class trading experiences to investors worldwide. Founded in March 2019, Longbridge holds 22 financial regulatory licenses or qualifications across the U.S., Hong Kong SAR, Singapore, and other markets, and has secured more than US$150 million in strategic investment from leading financial institutions and investment firms. Long Bridge Securities Pte. Ltd. is a licensed entity regulated by the Monetary Authority of Singapore (MAS) (Capital Markets Services Licence No.: CMS101211), holding a Capital Markets Services Licence and operating under an exempt financial adviser status.

About SIAS

SIAS actively promotes good corporate governance and transparency practices, investor rights, investor education and is the watchdog for investors in Singapore. SIAS extensively provides a variety of investor education programmes to its members and the investing community at large through collaborative partnership with financial institutions and listed companies interested in investor education as part of their corporate social responsibility agenda.

SIAS is run by an elected Management Committee comprising professionals who are volunteers and it is a registered Charity and an Institution of Public Character.

For more information about SIAS, please visit www.sias.org.sg.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/longbridge-and-sias-sign-mou-to-advance-investor-education-and-financial-literacy-in-the-ai-era-302919532.html

SOURCE Longbridge

Continue Reading

Technology

Klarna’s flexible payment options now available at Adorama, giving creators more ways to fuel their next project

Published

7 seconds ago

on

October 26, 2026

By

NEW YORK, Oct. 26, 2026 /PRNewswire/ — Adorama, a leading photography, video, audio, drone, and computer retailer, and Klarna, the everyday finance network, today announced that Klarna is now available as a payment option on Adorama.com, with availability on sister sites Scuba.com and SunnySports.com to follow. Adorama is a destination for photographers, filmmakers and content creators who are looking to buy cameras, lenses, lighting and professional video equipment. 

Starting today, Adorama customers shopping online can use Klarna to pay in full for smaller purchases like memory cards and camera bags, split the cost of a new lens or speedlight into four interest-free payments, or finance bigger investments, from professional camera bodies and drones to the laptops and editing rigs that turn footage into finished work.

“Our customers are buying gear they’ll rely on for years, so convenient payment solutions is an important part of the buying decision,” said Yoav Shargil, Chief Marketing Officer at Adorama. “Partnering with Klarna enables us to expand our reach to a new audience of shoppers, and adding this level of choice and flexibility underscores our commitment to making our offerings as accessible as possible.”

“Camera and video equipment is exactly the kind of considered purchase where flexibility matters,” said Lisa Robinson, Head of Partner Success, US East Coast and Canada at Klarna. “We’re proud to partner with Adorama to give creatives a more flexible way to invest in the tools and ideas that power their craft.”

To learn more, visit Adorama.com.

About Adorama Inc.
Adorama is a leading photography, video, audio, drone, and computer retailer, serving customers for over 50 years. Adorama has grown from its flagship NYC store to include four online retailers: Adorama, SunnySports, Scuba.com, and Printique. More than a camera store, Adorama works with creators throughout their journey, providing new, used and rental gear, education, and professional services, while fostering meaningful connections and lasting impact through community programs.

About Klarna
Klarna is the everyday finance network. With over 120 million global active Klarna users and 3.8 million transactions per day, Klarna’s AI-powered payments and commerce network is empowering people to pay smarter with a mission to be available everywhere for everything. Consumers can pay with Klarna online, in-store and through Apple Pay & Google Pay. Over 1.2 million retailers trust Klarna’s innovative solutions to drive growth and loyalty, including Uber, H&M, Saks, Sephora, Macy’s, Ikea, Expedia Group, Nike and Airbnb. Klarna is listed on the New York Stock Exchange (NYSE: KLAR). For more information, visit Klarna.com.

Press Contact
adorama@thebrandamp.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/klarnas-flexible-payment-options-now-available-at-adorama-giving-creators-more-ways-to-fuel-their-next-project-302919531.html

SOURCE Adorama

Continue Reading

Technology

Music IP Holdings Launches “Click-Through” License Portal for AI Technology Companies

Published

10 seconds ago

on

October 26, 2026

By

NASHVILLE, Tenn., Oct. 26, 2026 /PRNewswire/ — Music IP Holdings, Inc. (MIH) today launched a “Click-Through License Portal” that lets AI technology companies license its patented technologies online in minutes. MIH is a leading AI innovation licensing and technology development company setting the standard for authorized AI generation involving existing and new content.

The first-of-its-kind, custom-designed “Click-Through License Portal” allows MIH to quickly and efficiently provide cost-effective patent portfolio licenses to select companies so they can obtain the “freedom to operate” within and across AI markets. The new portal is designed for both technology and content companies that need to license the MIH AI derivatives workflow, Super Fan, Stems and other related patents in the portfolio: https://app.musiciprights.com/company-info

Today’s portal, offered to smaller companies through the MIH Strategic Innovation Partner (SIP) program, is separate from the licensing agreements with large content and technology companies that MIH began announcing in August.

“A great deal of work has gone into this process by our technology, legal and licensing teams. It represents a critical step in MIH’s evolution in 2026. We are laser-focused on protecting content owners and accelerating licenses for AI companies, all while enabling standards and value in the marketplace,” said Daniel Drolet, CEO of MIH.

MIH owns a patent portfolio built for the age of generative AI. The portfolio includes more than 28 patent families and more than 90 issued, allowed and pending assets that together claim the workflow by which AI generation services turn prompts of all types into finished outputs. That workflow runs from intake and interpretation of the request, through checks against rights holders’ content rules, generation, and post-generation review and marking, to controlled delivery under authorization and payment.

“Copyright asks whether something was copied; the MIH patents ask how it was made,” Drolet said. “The MIH portfolio covers those answers across all three major claim categories – methods, systems and software – so rights attach whether or not an output copies anything, and whether or not the output itself can be copyrighted.”

The MIH protections are directed to content in general rather than a single medium, and are being commercialized across music, voice, motion pictures, video, imagery, animation, publishing, and character and franchise IP, as well as name, image and likeness (NIL).

Media Contacts:
David Schwarz, press@musiciprights.com, (202) 905-6614
Kyle Boulia, kyle.boulia@forwardglobal.com
Ashley Hansen, ashley.hansen@forwardglobal.com

About Music IP Holdings, Inc.
Formed in early 2025, Music IP Holdings, Inc. (MIH) is an advanced AI innovation company that develops, files, manages and licenses a growing portfolio of patented technologies governing how AI-generated content is permissioned, generated, marked, distributed, tracked and monetized. The comprehensive portfolio protects both existing content and new AI-generated content while providing AI generation companies with a clear, licensed pathway to drive revenue and accelerate market growth.  www.musiciprights.com

View original content:https://www.prnewswire.com/news-releases/music-ip-holdings-launches-click-through-license-portal-for-ai-technology-companies-302919358.html

SOURCE Music IP Holdings

Continue Reading

Trending